Growth retardation and delayed puberty are unique features of IBD in children and are caused by both undernutrition and inflammation. The substantial effect of impaired growth and delayed puberty on quality of life creates particular difficulties for disease management. This Review focuses on the pathogenesis of disrupted growth and puberty in children with IBD and the emerging therapies for resolving inflammation and restoring growth.